Advertisement
Screener

Standard BioTools Inc. (LAB) Tax Withholding Paid on Stock Awards

1.7 / 5 stars · 27/80 Roast Me

Standard BioTools Inc. Tax Withholding Paid on Stock Awards

Standard BioTools Inc. (LAB) reported Tax Withholding Paid on Stock Awards of $376.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05

  • Standard BioTools Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $258.00K, a 29.00% increase year-over-year.
  • Standard BioTools Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $118.00K, a 156.52% increase year-over-year.
  • Standard BioTools Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $126.00K, a 180.00% increase year-over-year.
  • Standard BioTools Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $112.00K, a 60.00% increase year-over-year.
  • Standard BioTools Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $484.00K, a 5.45% increase from fiscal 2024.
  • Standard BioTools Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $459.00K, a 230.22% increase from fiscal 2023.
  • Standard BioTools Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $139.00K, a 34.12% decline from fiscal 2022.
  • Standard BioTools Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $211.00K, a 88.23% decline from fiscal 2021.
Period endPayment, Tax Withholding, Share-based Payment Arrangement 3 monthPayment, Tax Withholding, Share-based Payment Arrangement 6 monthPayment, Tax Withholding, Share-based Payment Arrangement 6 month as first filedPayment, Tax Withholding, Share-based Payment Arrangement 9 monthPayment, Tax Withholding, Share-based Payment Arrangement 9 month as first filedPayment, Tax Withholding, Share-based Payment Arrangement 12 month
2026-06-30$258.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$376.00K
10-Q · filed 2026-08-05
$502.00K
derived: sum of 3 quarters · filed 2026-08-05
$614.00K
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$118.00K
10-Q · filed 2026-05-06
$244.00K
derived: sum of 2 quarters · filed 2026-05-06
$356.00K
derived: sum of 3 quarters · filed 2026-05-06
$556.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$126.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$238.00K
derived: sum of 2 quarters · filed 2026-03-16
$438.00K
derived: sum of 3 quarters · filed 2026-08-05
$484.00K
10-K · filed 2026-03-16
2025-09-30$112.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$312.00K
derived: sum of 2 quarters · filed 2026-08-05
$358.00K
10-Q · filed 2025-11-04
$403.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$200.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$246.00K
10-Q · filed 2026-08-05
$291.00K
derived: sum of 3 quarters · filed 2026-08-05
$361.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$46.00K
10-Q · filed 2026-05-06
$91.00K
derived: sum of 2 quarters · filed 2026-05-06
$161.00K
derived: sum of 3 quarters · filed 2026-05-06
$488.00K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$45.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$115.00K
derived: sum of 2 quarters · filed 2026-03-16
$442.00K
derived: sum of 3 quarters · filed 2026-03-16
$459.00K
10-K · filed 2026-03-16
2024-09-30$70.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$397.00K
derived: sum of 2 quarters · filed 2025-11-04
$414.00K
10-Q · filed 2025-11-04
$414.00K
derived: sum of 4 quarters · filed 2026-03-16
2024-06-30$327.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15
$344.00K
10-Q · filed 2025-08-15
$344.00K
derived: sum of 3 quarters · filed 2026-03-16
$356.00K
derived: sum of 4 quarters · filed 2026-03-16
2024-03-31$17.00K
10-Q · filed 2025-05-06
$17.00K
derived: sum of 2 quarters · filed 2026-03-16
$29.00K
derived: sum of 3 quarters · filed 2026-03-16
$64.00K
derived: sum of 4 quarters · filed 2026-03-16
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$12.00K
derived: sum of 2 quarters · filed 2026-03-16
$47.00K
derived: sum of 3 quarters · filed 2026-03-16
$139.00K
10-K · filed 2026-03-16
2023-09-30$12.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$47.00K
derived: sum of 2 quarters · filed 2024-11-06
$139.00K
10-Q · filed 2024-11-06
$169.00K
derived: sum of 4 quarters · filed 2025-03-11
2023-06-30$35.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$127.00K
10-Q · filed 2024-08-06
$157.00K
derived: sum of 3 quarters · filed 2025-03-11
$259.00K
derived: sum of 4 quarters · filed 2025-03-11
2023-03-31$92.00K
10-Q · filed 2024-05-09
$122.00K
derived: sum of 2 quarters · filed 2025-03-11
$224.00K
derived: sum of 3 quarters · filed 2025-03-11
$216.00K
derived: sum of 4 quarters · filed 2025-03-11
2022-12-31$30.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$132.00K
derived: sum of 2 quarters · filed 2025-03-11
$124.00K
derived: sum of 3 quarters · filed 2025-03-11
$211.00K
10-K · filed 2025-03-11
2022-09-30$102.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$94.00K
derived: sum of 2 quarters · filed 2023-11-07
$181.00K
10-Q · filed 2023-11-07
$279.00K
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$8.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$79.00K
10-Q · filed 2023-08-08
$177.00K
10-Q · filed 2022-08-09
$177.00K
derived: sum of 3 quarters · filed 2023-08-08
$320.00K
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$87.00K
10-Q · filed 2023-05-09
$185.00K
derived: sum of 2 quarters · filed 2023-05-09
$328.00K
derived: sum of 3 quarters · filed 2023-05-09
$1.35M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$98.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
$241.00K
derived: sum of 2 quarters · filed 2023-03-14
$1.27M
derived: sum of 3 quarters · filed 2023-03-14
$1.79M
10-K · filed 2023-03-14
2021-09-30$143.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$1.17M
derived: sum of 2 quarters · filed 2022-11-09
$1.70M
10-Q · filed 2022-11-09
$1.77M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$1.55M
10-Q · filed 2022-08-09
$1.62M
derived: sum of 3 quarters · filed 2022-08-09
$1.75M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$525.00K
10-Q · filed 2022-05-09
$597.00K
derived: sum of 2 quarters · filed 2022-05-09
$722.00K
derived: sum of 3 quarters · filed 2022-05-09
$838.00K
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$72.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$197.00K
derived: sum of 2 quarters · filed 2022-03-08
$313.00K
derived: sum of 3 quarters · filed 2022-03-08
$459.00K
10-K · filed 2022-03-08
2020-09-30$125.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$241.00K
derived: sum of 2 quarters · filed 2021-11-09
$387.00K
10-Q · filed 2021-11-09
$460.00K
derived: sum of 4 quarters · filed 2022-03-08
2020-06-30$116.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$262.00K
10-Q · filed 2021-08-06
$335.00K
derived: sum of 3 quarters · filed 2022-03-08
$404.00K
derived: sum of 4 quarters · filed 2022-03-08
2020-03-31$146.00K
10-Q · filed 2021-05-07
$219.00K
derived: sum of 2 quarters · filed 2022-03-08
$288.00K
derived: sum of 3 quarters · filed 2022-03-08
$667.00K
derived: sum of 4 quarters · filed 2022-03-08
2019-12-31$73.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$142.00K
derived: sum of 2 quarters · filed 2022-03-08
$521.00K
derived: sum of 3 quarters · filed 2022-03-08
$629.00K
10-K · filed 2022-03-08
2019-09-30$69.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$448.00K
derived: sum of 2 quarters · filed 2020-11-09
$556.00K
10-Q · filed 2020-11-09
$747.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$379.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$487.00K
10-Q · filed 2020-08-07
$678.00K
derived: sum of 3 quarters · filed 2021-02-25
$690.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$108.00K
10-Q · filed 2020-05-11
$299.00K
derived: sum of 2 quarters · filed 2021-02-25
$311.00K
derived: sum of 3 quarters · filed 2021-02-25
$419.00K
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$191.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$203.00K
derived: sum of 2 quarters · filed 2021-02-25
$311.00K
derived: sum of 3 quarters · filed 2021-02-25
$358.00K
10-K · filed 2021-02-25
2018-09-30$12.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$120.00K
derived: sum of 2 quarters · filed 2019-11-08
$167.00K
10-Q · filed 2019-11-08
$100.00K
10-Q · filed 2018-11-06
$195.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$108.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$155.00K
10-Q · filed 2019-08-07
$100.00K
10-Q · filed 2018-08-08
$183.00K
derived: sum of 3 quarters · filed 2020-02-27
$183.00K
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$47.00K
10-Q · filed 2019-05-07
$75.00K
derived: sum of 2 quarters · filed 2020-02-27
$75.00K
derived: sum of 3 quarters · filed 2020-02-27
2017-12-31$28.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$28.00K
derived: sum of 2 quarters · filed 2020-02-27
$118.00K
10-K · filed 2020-02-27
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$90.00K
10-Q · filed 2018-11-06
2017-06-30$90.00K
10-Q · filed 2018-08-08
$46.00K
10-Q · filed 2017-08-08
2016-12-31$21.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$111.00K
10-K · filed 2019-03-18
2016-09-30$90.00K
10-Q · filed 2017-11-07
2015-12-31$151.00K
10-K · filed 2018-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01